Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Gynecologic Neoplasms 13. January 2026
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 16152  Previews Next
   
   Articles 1 - 20 / 323028  
   
Multiomic profiling of ER-positive HER2-negative breast cancer reveals markers associated with metastatic spread.
Breast Cancer Res
Mosquim Junior S, Zamore M, Vallon-Christersson J, Rydén L, Levander F.
PMID: 41526910 [PubMed - as supplied by publisher]


Identification of novel exosomal miRNAs and their role in diagnosis and prognosis of triple negative breast cancer.
BMC Cancer
Choudhary A, Poojary SS, Jain P, Chaturvedi H, Das BC.
PMID: 41526862 [PubMed - as supplied by publisher]


Ultrasound for predicting pathological response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review and meta-analysis.
BMC Cancer
Shi QF, Hu PF, Liu YH.
PMID: 41526850 [PubMed - as supplied by publisher]


Breast cancer survivor's sexual health unmet supportive care needs: a mixed-methods study.
J Cancer Surviv
Ferreira D, Quinta-Gomes AL, Pieramico S, Weiderpass E, Santana R, Andersson G, Mendes-Santos C.
PMID: 41526763 [PubMed - as supplied by publisher]


Mendelian randomization study of GLP-1R effects on ovarian cancer subtypes mediated by metabolic factors.
Commun Med (Lond)
Liu J, Chen Z, Yang Q, Lin H, Wang S, Li M, Wang T, Zhao Z, Xu M, Chen Y, Xu Y, Lu J, Gong Q, Ning G, Wang L, Wang W, Bi Y, Zheng J.
PMID: 41526703 [PubMed - as supplied by publisher]


Multidimensional risk impact of obesity on breast cancer incidence, treatment, and prognosis.
Int J Obes (Lond)
Liu Y, Xu S, Yang H, Wang Y.
PMID: 41526462 [PubMed - as supplied by publisher]


A qualitative study exploring Malaysian women's preferences for authority or emotional appeals in public health messages promoting breast cancer screening.
Sci Rep
Hing NYL, Kuan PX, Mohamad EMW, Loo CE, Perialathan K, Mohamad Norzlen AN, Yip YY, Zainudin WMS, Abdul Samad S, Mohd Said Z, Hwong WY.
PMID: 41526414 [PubMed - in process]


Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial.
BMJ

PMID: 41526043 [PubMed - in process]


Night shift work and breast cancer risk in healthcare workers: a systematic review and meta-analysis.
Occup Med (Lond)
Esposito G, Bravi F, Santucci C, Zunarelli C, Violante FS, La Vecchia C, Negri E, Turati F.
PMID: 41525351 [PubMed - indexed for MEDLINE]


Metabolic and Hormonal Impact of Subclinical Hypothyroidism in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study from South India.
Clin Ter
Acharya A, Sulakhe R, Hasamnis VA, Panda A.
PMID: 41525122 [PubMed - indexed for MEDLINE]


Quantitative vs Qualitative analysis of breast lesions on dynamic contrast-enhanced Magnetic Resonance Imaging.
Clin Ter
Kaur N, Kakkera S, Raj A, Verma M, Sandhu A, Patra A, Singh P.
PMID: 41525116 [PubMed - indexed for MEDLINE]


Genetic Testing for All Breast Cancer Patients: The GET FACTS Randomized Clinical Trial.
JAMA Netw Open
Weiss A, Braun D, Stopfer J, Zhao J, McGrath M, Bradshaw KR, Rosito MS, Davis D, Garber JE, King TA.
PMID: 41525075 [PubMed - indexed for MEDLINE]


Wnt ligands in breast cancer metastasis: unraveling their dual roles and therapeutic potential.
Mol Biol Rep
Asadi A, Molavand M, Vaghari-Tabari M, Yousefi B.
PMID: 41524847 [PubMed - in process]


Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?
Osteoporos Int
Marcucci G, Biver E, Body JJ, Campusano C, Cannata-Andía J, Confavreux C, de Villiers TJ, Ebeling PR, Hadji P, Kendler D, El Maghraoui A, Napoli N, Veronesi P, Rizzoli R, Brandi ML.
PMID: 41524787 [PubMed - as supplied by publisher]


Screening of metabolic markers related to molecular typing of breast cancer based on 1H NMR metabonomics.
Adv Clin Exp Med
Xu M, Huang W, Huang X, Shu H, Ke W, Zhang Y, Yang Y.
PMID: 41524717 [PubMed - as supplied by publisher]


Personalizing therapies over the course of hormone receptor-positive/HER2-negative metastatic breast cancer.
CA Cancer J Clin
Singareeka Raghavendra A, Damodaran S, Barcenas CH, Fuqua SA, Layman RM, Tripathy D.
PMID: 41524544 [PubMed - indexed for MEDLINE]


Evaluation of breast cancer symptoms and risk factors in women: the case of Türkiye.
Rev Esc Enferm USP
Ahi S, Ayata MK, Seyhan M.
PMID: 41524420 [PubMed - indexed for MEDLINE]


Information Needs and Preferences of Men With Breast Cancer: A Qualitative Analysis of Internet Forum Posts.
Breast J
Schemmel N, Lauberger J, Lühnen J, Steckelberg A.
PMID: 41524023 [PubMed - indexed for MEDLINE]


Diagnostic sensitivity of mammography and magnetic resonance imaging for ductal carcinoma in situ in high-risk breast cancer screening: A systematic-review and meta-analysis.
Chin J Cancer Res
Li M, Lin Y, Poelhekken K, Greuter MJW, de Bock GH, Dorrius MD.
PMID: 41523840 [PubMed]


A multicenter study of a predictive model for pathological complete response after neoadjuvant therapy in breast cancer using multimodal digital biomarkers.
Chin J Cancer Res
Yang Z, He J, Li T, Liu C, Wang Y, Ren Y, Zhao W, Chiau CC, Li Q, Xu L, Yue J, Liang T, Jin L, Fang X, Shi B, Shi Z, Yuan P, Gnant M.
PMID: 41523834 [PubMed]


   
   Articles 1 - 20 / 323028    Page 1 of 16152  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1